Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma

Background: Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for those patients with unresectable tumors. Neoadjuvant therapy is not part of th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Endocrinol (Lausanne)
Hlavní autoři: Nava, Carla Fernanda, Scheffel, Rafael Selbach, Cristo, Ana Patrícia, Ferreira, Carla Vaz, Weber, Shana, Zanella, André Borsatto, Paixão, Francisco Costa, Migliavaca, Alceu, Guimarães, José Ricardo, Graudenz, Marcia Silveira, Dora, José Miguel, Maia, Ana Luiza
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6817485/
https://ncbi.nlm.nih.gov/pubmed/31695679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00712
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky